MNPR Monopar Therapeutics Inc. - Common Stock

NASDAQ · Biotechnology · View on SEC EDGAR ↗
$57.81
Price · May 20, 2026
Fundamentals as of May 14, 2026

MNPR Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$57.81
Market Cap
P/E (TTM)
EPS (TTM)
Revenue (TTM)
$0
Div Yield
ROE
Debt/Equity
52W Range
$28 – $105

MNPR Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income $0
Flat — no change across 7 periods
2016-12-31 2025-12-31
EPS
Free Cash Flow
Margins

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
MNPR
Peer Median

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
MNPR
Peer Median

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
MNPR
Peer Median

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
MNPR
Peer Median

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
MNPR
Peer Median

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
MNPR
Peer Median

MNPR Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 20 analysts
  • Strong Buy 5 25.0%
  • Buy 14 70.0%
  • Hold 1 5.0%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

12-Month Price Target

13 analysts · 2026-05-17
Median target $109.00 +88.5%
Mean target $112.62 +94.8%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
-0.28%
Period EPS Actual EPS Est Surprise
March 31, 2026 $-0.46 $-0.85 0.39%
Dec. 31, 2025 $-0.64 $-0.50 -0.14%
Sept. 30, 2025 $-0.48 $-0.44 -0.04%
June 30, 2025 $-0.35 $-0.48 0.13%
March 31, 2025 $-0.38 $-0.69 0.31%
Dec. 31, 2024 $-2.75 $-0.43 -2.3%

Peer Comparison Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
MNPR
UPB $1.47B -10.2 20.4% -5026.0% -38.3%
EBS $644M 13.3 -28.8% 7.1% 9.9%
REPL $752M -3.2 -55.1%
ASMB $539M -61.8 153.5% -8.5% -5.5%
SGMT -3.7 -42.3%
FBRX $353M -5.8 106.6% -2555.2% -86.9%
ENTA $256M -3.1 -3.4% -125.4% -103.5%
IPSC $87M -7.1 1556.8% -8.8% -5.2%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Income Statement 12
Annual Income Statement data for MNPR
Metric Trend 202520242023202220212020201920182017
Revenue Flat — no change across 6 periods $0 $0 $0 · · · $0 $0 $0
R&D Expense 9-point trend, +958.9% $10M $13M $6M $8M $6M $4M $2M $2M $935.3K
SG&A Expense 9-point trend, +483.1% $7M $3M $3M $3M $3M $2M $2M $2M $1M
Operating Expenses 9-point trend, +0.6% $17M $16M $9M $11M $9M $7M $4M $3M $17M
Operating Income 9-point trend, -0.6% $-17M $-16M $-9M $-11M $-9M $-7M $-4M $-3M $-17M
Interest Income 3-point trend, +596.3% $3M $404.0K $429.0K · · · · · ·
Pretax Income 5-point trend, +17.1% $-14M $-16M $-8M · · · · $-3M $-17M
Income Tax 9-point trend, +122.5% $800 $800 $800 $800 $0 $18.4K $0 $-70.8K $-3.6K
Net Income 9-point trend, +17.1% $-14M $-16M $-8M $-11M $-9M $-6M $-4M $-3M $-17M
EPS (Basic) 4-point trend, -122.9% $-1.85 $-4.11 $-3.04 $-0.83 · · · · ·
Shares (Basic) 5-point trend, -40.6% 7,411,121 3,790,202 2,764,790 12,718,166 12,471,217 · · · ·
EBITDA 7-point trend, -375.0% · $-16M $-9M $-11M $-9M $-7M $-4M $-3M ·
Balance Sheet 16
Annual Balance Sheet data for MNPR
Metric Trend 202520242023202220212020201920182017
Cash & Equivalents 9-point trend, +588.4% $62M $46M $7M $8M $20M $17M $13M $7M $9M
Other Current Assets 7-point trend, +305.7% $63.7K $78.9K $66.4K $46.0K $217.7K $62.7K $15.7K · ·
Current Assets 9-point trend, +1438.3% $140M $60M $7M $13M $21M $17M $13M $7M $9M
Other Non-current Assets 4-point trend, -100.0% · · · · $0 $68.9K $122.4K $65.7K ·
Total Assets 9-point trend, +1316.9% $141M $60M $7M $13M $21M $17M $13M $7M $10M
Accounts Payable 9-point trend, +777.1% $3M $2M $2M $3M $2M $1M $724.2K $399.6K $311.9K
Current Liabilities 9-point trend, +777.1% $3M $5M $2M $3M $2M $1M $724.2K $399.6K $311.9K
Capital Leases 5-point trend, +154920.00 $154.9K $0 $0 $8.4K $0 · · · ·
Total Liabilities 9-point trend, +826.7% $3M $5M $2M $3M $2M $1M $724.2K $399.6K $311.9K
Common Stock 9-point trend, -28.0% $6.7K $6.1K $3.0K $12.9K $12.6K $11.5K $10.6K $9.3K $9.3K
Paid-in Capital 6-point trend, +120.7% · · · $62M $60M $48M $39M $29M $28M
Retained Earnings 9-point trend, -385.7% $-90M $-76M $-60M $-52M $-41M $-32M $-26M $-22M $-18M
AOCI 9-point trend, +131389.00 $131.4K $36.0K $-14.1K $8.9K $-3.2K $-7.9K $-11.0K $-2.4K $0
Stockholders' Equity 9-point trend, +1332.8% $138M $55M $6M $10M $19M $16M $13M $7M $10M
Liabilities + Equity 9-point trend, +1316.9% $141M $60M $7M $13M $21M $17M $13M $7M $10M
Shares Outstanding 9-point trend, -28.0% 6,692,140 6,102,560 2,980,900 12,946,573 12,598,125 11,453,465 10,587,632 9,291,421 9,291,421
Cash Flow 10
Annual Cash Flow data for MNPR
Metric Trend 202520242023202220212020201920182017
Stock-based Comp 4-point trend, +194.8% $5M $1M $2M $2M · · · · ·
Deferred Tax 9-point trend, +0.00 $0 $0 $0 $0 $0 $0 $0 $-71.6K $0
Operating Cash Flow 9-point trend, -364.4% $-12M $-6M $-8M $-7M $-7M $-5M $-3M $-3M $-3M
Investing Cash Flow 5-point trend, -63453114.00 $-63M $-14M $5M $-5M $0 · · · ·
Stock Issued 8-point trend, -100.0% $0 $4M $2M $109.3K · $8M $0 $0 $5M
Stock Repurchased 2-point trend, +34999957.00 $35M $0 · · · · · · ·
Net Stock Activity 4-point trend, +4202245.00 · $4M $2M · · $8M · $0 ·
Financing Cash Flow 9-point trend, +860.3% $92M $59M $2M $32.9K $11M $8M $9M $-206.3K $10M
Net Change in Cash 9-point trend, +131.8% $16M $39M $-920.1K $-12M $4M $4M $6M $-3M $7M
Taxes Paid 3-point trend, -100.0% · · · · $0 $-11.1K $53 · ·
Profitability 6
Annual Profitability data for MNPR
Metric Trend 202520242023202220212020201920182017
Operating Margin 3-point trend, -524.3% · · · -49611.0% -37992.2% -7947.2% · · ·
Net Margin 3-point trend, -543.2% · · · -49511.0% -37892.2% -7697.7% · · ·
EBITDA Margin 3-point trend, -524.3% · · · -49611.0% -37992.2% -7947.2% · · ·
ROA 7-point trend, -23.1% · -46.1% -81.7% -62.3% -48.7% -41.7% -40.9% -37.4% ·
ROE 7-point trend, -16.7% · -52.0% -137.8% -93.1% -45.3% -38.0% -49.0% -44.5% ·
ROIC 2-point trend, +39.0% · -29.4% · · · · · -48.1% ·
Liquidity & Solvency 2
Annual Liquidity & Solvency data for MNPR
Metric Trend 202520242023202220212020201920182017
Current Ratio 5-point trend, -77.2% · · 4.2 4.2 · 14.3 18.3 18.3 ·
Quick Ratio 5-point trend, -76.0% · · 4.1 2.6 · 14.2 18.2 17.3 ·
Efficiency 1
Annual Efficiency data for MNPR
Metric Trend 202520242023202220212020201920182017
Asset Turnover 7-point trend, +0.00 · 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ·
Per Share 2
Annual Per Share data for MNPR
Metric Trend 202520242023202220212020201920182017
Book Value / Share 7-point trend, +1111.2% · $9.02 $0.37 $0.78 $1.50 $1.37 $1.19 $0.74 ·
Cash / Share 7-point trend, +912.1% · $7.51 $0.49 $0.63 $1.61 $1.46 $1.25 $0.74 ·
Valuation (TTM) 6
Annual Valuation (TTM) data for MNPR
Metric Trend 202520242023202220212020201920182017
Revenue TTM Flat — no change across 9 periods $0 $0 $0 $0 $0 $0 $0 $0 $0
Net Income TTM 9-point trend, +17.1% $-14M $-16M $-8M $-11M $-9M $-6M $-4M $-3M $-17M
Market Cap 6-point trend, -84.7% · $134M $25M $153M $202M $350M $879M · ·
P/B 6-point trend, -96.5% · 2.4 4.5 15.2 10.7 22.3 69.6 · ·
P / Tangible Book 6-point trend, -85.8% 3.2 2.4 4.5 15.2 10.7 22.3 · · ·
P / Cash Flow 6-point trend, +92.8% · -21.0 -3.2 -21.2 27.6 -75.2 -291.2 · ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Income Statement
2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue $0$0$0
Operating Margin % -49611.0%-37992.2%
Net Income $-14M$-16M$-8M$-11M$-9M
Balance Sheet
2025-12-312024-12-312023-12-312022-12-312021-12-31
Current Ratio 4.24.2
Quick Ratio 4.12.6

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.